Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21, S214